DIABETES is no longer simply a medical condition affecting individuals; it has emerged as one of the most pressing public health challenges. In Pakistan, the situation is particularly alarming, demanding immediate attention from healthcare professionals, policymakers, the pharmaceutical industry and society at large.
Pakistan at the crossroads Pakistan is facing an extraordinary burden of diabetes. According to estimates from the International Diabetes Federation (IDF), the country ranks among those with the highest prevalence of diabetes worldwide. What makes this situation even more concerning is that a substantial proportion of people living with diabetes remains undiagnosed.
The silent nature of diabetes By the time the disease is diagnosed, significant damage may already have occurred. Common warning signs include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision and slow wound healing. As such, early diagnosis creates opportunities for timely intervention, improved treatment outcomes and prevention of long-term complications.
Effective treatment For diabetic patients, appropriate and consistent disease management is essential. Modern diabetes care has evolved significantly, offering treatment approaches that address blood glucose control, cardiovascular and kidney health issues.
Nevertheless, medicines are effective only when patients can access them, understand their treatment plans and follow them consistently.Pharmaceutical industry The pharmaceutical industry has an important responsibility in addressing Pakistan’s diabetes burden. Our role must extend beyond the development, manufacturing and distribution of quality medicines. At High-Q Pharmaceuticals, we recognise the importance of advancinghealthcarethroughquality, innovation and a patient-centred approach. We firmly believe that meaningful progress against diabetes requires collaboration between industry, healthcare institutions, medical professionals, regulators and public health organisations.
Building a national response Pakistan needs a coordinated, long-term strategy to address the growing diabetes burden. This strategy must integrate prevention, early detection, evidence-based treatment, professional education and equitable healthcare access.
As a healthcare professional and leader in the pharmaceutical industry, I believe that our collective success should ultimately be measured by the health and wellbeing of the people we serve.